Skip to main content
. Author manuscript; available in PMC: 2020 Oct 1.
Published in final edited form as: Ann Surg Oncol. 2019 Jul 24;26(10):3166–3177. doi: 10.1245/s10434-019-07564-9

Figure 1. Patient Flow Diagram, Women with cT1-4c, cN1-3, HR+ Invasive Lobular Carcinoma, National Cancer Data Base, 2004-2014.

Figure 1.

ACT, adjuvant chemotherapy. AET, adjuvant endocr ine therapy. NACT, neoadjuvant chemotherapy. NET, neoadjuva nt endocrine therapy. Boldface indicates inclusion in fina l study cohort (n=5,942). * Includes patients diagnosed in 2015. **Only included in calculation of NACT and NET rates over time (N=18,931). ***Only included in calculation of NACT and NET rates over time (N=18,931) as well as unadjusted overall survival analyses (N=18,154).